Covid 19 coronavirus: Why the three biggest vaccine makers failed on Covid-19
16 Feb, 2021 07:05 PM
9 minutes to read
GlaxoSmithKline, Merck and Sanofi are now left playing catch-up in the vaccine race. Photo / 123RF
Financial Times
GlaxoSmithKline, Merck and Sanofi are left playing catch-up to upstarts with new technology. As pharmaceutical companies raced to develop Covid-19 vaccines, crossing the finishing line in record time, the world s three biggest vaccine makers were also-rans.
GlaxoSmithKline, Merck and Sanofi are now left playing catch-up, after upstarts including Moderna and BioNTech demonstrated their mastery of new technologies that will shape the industry for years to come.
New Jersey-based Merck recently dropped its vaccine development programme completely, while Paris-based Sanofi and the UK s GSK are having to redo an early-stage trial of the jab they are jointly developing, after a dosing mistake.
Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.
Drugmakers GlaxoSmithKline and Sanofi said that their potential COVID-19 vaccine won’t be ready until late next year because they need to improve the shot.
GSK, Sanofi say COVID-19 shot won t be ready until late accesswdun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from accesswdun.com Daily Mail and Mail on Sunday newspapers.
GSK, Sanofi say COVID-19 vaccine won t be ready until late 2021 680news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 680news.com Daily Mail and Mail on Sunday newspapers.